Streetbeat News

Stock Prices

SLCA

US Silica Holdings (NYSE:SLCA) reported Q4 adjusted EPS of $0.28, surpassing the $0.25 estimate, but its sales of $336.00M fell short of the $343.72M estimate. This represents a 34.88% decrease in earnings and an 18.63% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:02 am

HSIC

Henry Schein (NASDAQ:HSIC) reported Q4 adjusted EPS of $0.66, missing the $0.70 estimate, and sales of $3.02B, missing the $3.04B estimate. This represents a 51.11% decrease in earnings and a 10.50% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:02 am

LOW

Lowe's Companies reported a 6.2% decrease in Q4 comparable sales, attributed to a slowdown in DIY demand and unfavorable January winter weather.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:02 am

CLVT

Clarivate (NYSE:CLVT) reported Q4 2023 adjusted EPS of $0.23, surpassing the $0.21 estimate, with sales of $683.70M also beating the $679.68M estimate, marking a 1.24% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:01 am

LOW

Lowe's Companies (NYSE:LOW) reported Q4 earnings of $1.58 per share, missing the $1.68 estimate, and sales of $18.60B, beating the $18.45B estimate. Earnings decreased by 30.7% and sales by 17.13% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:01 am

ARQT

Arcutis Biotherapeutics (NASDAQ:ARQT) reported Q4 2023 earnings with a GAAP EPS of $(0.72), surpassing the $(0.76) estimate. Sales reached $13.53M, exceeding the $11.34M forecast, marking a 356.81% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:55 am

ARQT

Arcutis Biotherapeutics (NASDAQ:ARQT) reported Q4 GAAP EPS of $(0.72), surpassing the $(0.78) estimate, and sales of $13.53M, exceeding the $11.34M estimate. This represents a 38.98% improvement in EPS and a 356.81% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:52 am

ROKU

Wells Fargo analyst Steven Cahall downgraded Roku (NASDAQ:ROKU) from Equal-Weight to Underweight and reduced the price target from $77 to $51.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:35 am

BNS

Bank of Nova Scotia (NYSE:BNS) reported Q1 adjusted EPS of $1.24, surpassing the $1.21 estimate, and sales of $6.20B, exceeding the $6.12B estimate. This represents a 7.31% decrease in EPS and a 4.29% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:33 am

TILE

Interface (NASDAQ:TILE) reported Q4 adjusted EPS of $0.41, surpassing the $0.23 estimate, and sales of $325.10M, exceeding the $321.80M estimate. This represents a 32.26% increase in EPS and a 3.12% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:31 am